The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis.
about
BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumoursExpression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factorsWidespread expression of BORIS/CTCFL in normal and cancer cellsBrother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer.BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomasThe structural complexity of the human BORIS gene in gametogenesis and cancer.BORIS/CTCFL is an RNA-binding protein that associates with polysomes.Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.A polymorphic minisatellite region of BORIS regulates gene expression and its rare variants correlate with lung cancer susceptibilityBreast cancer and protein biomarkers.Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells.The prognostic role of BORIS and SOCS3 in human hepatocellular carcinomaExpression analysis of BORIS during pluripotent, differentiated, cancerous, and non-cancerous cell states.CTCF induces histone variant incorporation, erases the H3K27me3 histone mark and opens chromatin.Expression of the cancer-testis antigen BORIS correlates with prostate cancer.The male germ cell gene regulator CTCFL is functionally different from CTCF and binds CTCF-like consensus sites in a nucleosome composition-dependent manner.Investigation of fusion gene expression in HCT116 cells.Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study.New hypotheses for large-scale epigenome alterations in somatic cancer cells: a role for male germ-cell-specific regulators.Increased expression of brother of the regulator of imprinted sites in peripheral blood neutrophils is associated with both benign and malignant breast lesions.BORIS: a key regulator of cancer stemness
P2860
Q24647085-FA2CB250-30A6-4254-93C7-61F8631F8612Q24685814-C6AF79CE-FB44-44D0-920D-A0C8F91FE03FQ27331401-90141AA1-752A-4F50-A4AD-5BFD52F0A9E7Q30354418-F3F7CAC9-0041-4DD7-A289-2D5C035E6D81Q33543790-027BE65A-E8C4-41CD-9A98-BCCA48A7AA2DQ33747803-52540B91-7A1F-4AF9-B3FB-AC1A52E2A313Q35054487-8842C4B1-0A47-4CC4-A52B-93476C13441BQ36282754-5EE46D93-37B7-4D71-A6F0-98FB6420F255Q36293822-59008195-6719-4FB8-B3A7-20D25A0D9C23Q36998205-9862A2DF-48B3-40F8-B6AA-BE065BA295C0Q37151432-44321438-BE74-4E56-A6C1-9228046736C5Q37527713-2F8770DA-1A5D-4F18-948A-6AE0993DBE57Q37618285-410045C1-C5B5-4DE9-BE38-59A32A1C1D43Q37727284-DA5C4C17-F822-4185-9187-E34C0023B796Q38306384-0883200F-0C75-476B-8098-788E1BA3AF9EQ38949804-638146B9-1A8B-4FF7-B5E7-A8E13B94514AQ39079438-61EAF486-AB97-4166-8CC3-3F535E5AD474Q42121580-03BD3E1F-4A61-43F8-88A8-8583F2232CF6Q47097518-3F952A8F-83CA-4A96-8419-7D60F6634F3AQ51109227-6607023B-6C22-4ECE-AD15-07D00DE128DCQ53306166-100DB358-5842-442B-B3EA-257FFD8DF814Q53762384-E181E7A1-78EE-4A73-A86D-AC9EA4161587Q57482782-ED818E62-D8C3-4D5A-BB4B-37F41578A201
P2860
The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The potential of BORIS detecte ...... early marker of tumorigenesis.
@ast
The potential of BORIS detecte ...... early marker of tumorigenesis.
@en
The potential of BORIS detecte ...... early marker of tumorigenesis.
@nl
type
label
The potential of BORIS detecte ...... early marker of tumorigenesis.
@ast
The potential of BORIS detecte ...... early marker of tumorigenesis.
@en
The potential of BORIS detecte ...... early marker of tumorigenesis.
@nl
prefLabel
The potential of BORIS detecte ...... early marker of tumorigenesis.
@ast
The potential of BORIS detecte ...... early marker of tumorigenesis.
@en
The potential of BORIS detecte ...... early marker of tumorigenesis.
@nl
P2093
P1476
The potential of BORIS detecte ...... early marker of tumorigenesis.
@en
P2093
Carlos Richard
Dawn Farrar
Elena Klenova
France Docquier
Igor Chernukhin
M Dolores Delgado
Melissa Smart
Metodi Metodiev
Naresh Pore
Nelson Fernandez
P304
P356
10.1158/1078-0432.CCR-05-2731
P407
P433
P577
2006-10-01T00:00:00Z